Singapore markets closed

NeuroSense Therapeutics Ltd. (NRSN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7200+0.0225 (+1.33%)
At close: 03:40PM EDT
1.7100 -0.01 (-0.58%)
After hours: 04:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
-
0
0
0
Operating expenses
Research development
-
3,082
2,495
898
Selling general and administrative
-
2,505
393
337
Total operating expenses
-
5,587
2,888
1,235
Operating income or loss
-
-5,587
-2,888
-1,235
Interest expense
-
-
1
5
Total other income/expenses net
-
2,700
-
18
Income before tax
-
-4,041
-2,828
-1,222
Income from continuing operations
-
-4,041
-2,828
-1,222
Net income
-
-4,041
-2,828
-1,222
Net income available to common shareholders
-
-4,041
-2,828
-1,222
Basic EPS
-
-0.65
-0.26
-0.11
Diluted EPS
-
-0.65
-0.26
-0.11
Basic average shares
-
6,243
10,944
10,944
Diluted average shares
-
6,243
10,944
10,944
EBITDA
-
-5,584
-2,824
-1,235